No Detail Found!

Evaluation of improvement in renal function after first-line chemotherapy in multiple myeloma patients presenting with renal impairment

Author(s)
Syed Abdul Mannan Hamdani Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan
Abdul Wahab Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan
Musa Azhar Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan
Faiza Iftikhar Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan
Bushra Ahsan Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan
Usman Ahmad Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan
Abstract
Objective: To evaluate the effect of response to first-line chemotherapy on renal functions in multiple myeloma (MM) patients. Study Design: Cross-sectional study. Place and Duration of Study: Shaukat Khanum Memorial Cancer Hospital, Lahore, from Jan 2013 to Dec 2017. Methodology: Multiple myeloma patients with renal impairment (RI) at baseline were included. Data was collected from the hospital registry.The variables assessed pre and post first-line chemotherapywere age, gender, initial estimated glomerular filteration rate and serum creatinine levels. Progression-free survivaland overall survival (OS) was calculated for both groups of patients i.e those who had improvement in renal funtions and those who did not show improvement. Kaplan-Meier curves were drawn, and SPSS-20 was used for data analysis. Results: Mean age was 48 ± 7 years. Out of 139 myeloma patients, 35 (25.1%) had RI at baseline. Males were 23 (65.7%), while females were 12 (34.3%). Cyclophosphamide, thalidomide and deamethsone (CTD)were used in the majority 30 (85.7%) followed by boretzomib, thalidomide and dexamethasone (VTD) in 2 (5.7%) patients. Boretezomib and dexamethasone (BorDex), lenalidomide and dexamethasone (Len Dex), lenalidomde, cyclophosphamide and dexamethasone (LCD) were given to 1 (2.8%) patient each. Serum creatinine levels normalized in 19 (54.3%). Dialysis was required in 11 (31.4%) patients out of which 3 (8.6%) got dialysis-independent while 8 (22.9%) patients remained dialysis-dependent. The medianoverall survival in whom creatinine levels normalized was 35 months while it was 15 months in those in whom it did not normalize. Conclusion: Prompt administration of chemotherapy regimens can lead to an improvement in renal functions and ultimately have a substantialeffect on survival outcomes.
Publication Details
Page(s) 1431-1435
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 71, Issue: 4, Year: 2021

Request the full text from PASTIC

Keywords
Lenalidomide, Estimated glomerular filtration rate, Cyclophosphamide and dexamethasone, Cyclophosphamde, Boretezomib, Renal impairment, Boretzomib and dexamethasone, Thalidomide and dexamethasone, Thalidomide and dexamethasone, Thalidomide and dexamethasone, Thalidomide and dexamethasone, Multiple myeloma.
0

Citations

0

Downloads

91

Views